USPTO trademark

ANTIBODIES BY DESIGN

RegisteredUSPTOWord markClass 5Class 42

"ANTIBODIES BY DESIGN" is a word mark owned by Xencor, Inc., filed at the USPTO on July 23, 2018. It is registered and covers classes 5 and 42.

View Xencor, Inc. portfolio Get this data via the API

Data current as of October 4, 2022Official USPTO record

As filed with the USPTO

Status: Registered; Since October 4, 2022
Filed: July 23, 2018
Registered: October 4, 2022
Expires: Not recorded
Application no.: 88049386
Registration no.: 6866551
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 2 classes

Ownership

Who owns ANTIBODIES BY DESIGN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Xencor, Inc.

XNCR · Pasadena, United States

40 trademarks in the portfolioView company

Representative

Gabrielle A. Holley

Holley & Menker, P.A.

Goods and services

What the mark covers

The products and services ANTIBODIES BY DESIGN is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders
42Class 42 · Computer and Scientific Services
Medical and scientific research and development services for third parties in the field of pharmaceuticals; scientific consulting services for third parties in the field of pharmaceuticals

History

What has happened so far

Steps recorded by the USPTO, newest first.

March 17, 2023Applicant/correspondence changes (non-responsive) entered
March 17, 2023Teas change of correspondence received
March 17, 2023Attorney/dom.rep.revoked and/or appointed
March 17, 2023Teas revoke/app/change addr of atty/dom rep received
March 17, 2023Teas change of owner address received
October 4, 2022Notice of registration confirmation emailed
October 4, 2022Registered-principal register
September 2, 2022Notice of acceptance of statement of use e-mailed
September 1, 2022Allowed principal register - sou accepted
August 8, 2022Statement of use processing complete

10 earlier steps on the official record.

FAQ

About ANTIBODIES BY DESIGN

Who owns the trademark "ANTIBODIES BY DESIGN"?

The USPTO trademark "ANTIBODIES BY DESIGN" (application 88049386) is owned by Xencor, Inc.

What is the status of "ANTIBODIES BY DESIGN"?

Its status at the USPTO is: registered.

When was "ANTIBODIES BY DESIGN" registered?

It was registered on October 4, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ANTIBODIES BY DESIGN and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2d10-ea6f-7729-b136-9c4debd800c6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2d10-ea6f-7729-b136-9c4debd800c6",
  "object": "trademark",
  "mark_text": "ANTIBODIES BY DESIGN",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88049386",
  "filing_date": "2018-07-23",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Xencor, Inc.",
      "entity_id": "ent_019ebbb6-74b5-759e-822d-79d5d96b0454"
    }
  ]
}